Rates today
  • Prime rate 6.75% flat
  • Fed funds 3.63% flat
  • SOFR 3.65% down0.01
  • Treasury 1Y 4.04% up0.04
  • Treasury 10Y 4.70% down0.02
Updated: EST

This product uses the FRED® API but is not endorsed or certified by the Federal Reserve Bank of St. Louis.

Applications Open

Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)

Deadline
August 11, 2027
Funding
Up to $150,000
Geography
National
Funder
National Institutes of Health

Grant Overview

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA’s current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary…

Eligibility and Program Details